№ lp_1_2_49365
File format: docx
Character count: 18292
File size: 239 KB
Facility:
ABC Hospital
Test System:
Commercial Identification System XYZ
Note:
Test System Primary SOPs include
Method Verification:
Instrument received and test system verification completed in year . Streamlined microbial identification was verified in year ______ (documented QC performance for 3 consecutive lot numbers of gram-positive and gram-negative panels from 3 different shipments that spanned 3 consecutive seasons).
Testing personnel:
Training of Personnel: Completion of training documented in_.
Competency Assessment:
New employees 6 months and 12 months after initial training and annually thereafter.
Proficiency Testing:
Rotate personnel; all personnel review results. Proficiency testing records filed in_______.
Summary of Isolates:
During the assessment period, ID was performed on # isolates
Environment:
Temperature Monitoring: Temperature monitoring records for refrigerators, freezers, and ambient range are performed and corrective action taken as per LAB-SOP-XXX and checklist requirements XYZ.
Test System and Reagents Information:
Manufacturer: Package insert contains system performance data and describes testing principle and procedure, QC recommendations (including streamlined QC), and limitations.
Summary of in-house data from streamlined QC testing:
Streamlined QC testing was performed according to SOP ______.
Summary of in-house data from routine instrument performance checks:
Instrument checks were done according to SOP ______.
Summary of corrected reports and physician complaints:
Documentation located ____.
Frequency of error occurrence:
Unlikely (once every 2-3 years) Occasional (once per year) Probable (once per month)
Severity of harm to patient:
Negligible (temporary discomfort) Minor (temporary injury; not re
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
N/A
Topic:
Risk Assessment, Quality Control Plan
Document Type:
Template
Organization:
Abbott Point of Care
Author:
N/A
Target Audience:
Laboratory staff, Laboratory Directors
Effective Period:
N/A
Approval Date:
N/A
Date of Revisions:
N/A
Year:
2015
Region / City:
United States
Subject:
Antimicrobial Susceptibility Testing
Document Type:
Template
Organization:
Regional Medical Center
Author:
N/A
Target Audience:
Laboratory personnel involved in AST testing
Effective Period:
N/A
Approval Date:
N/A
Modification Date:
N/A
Note:
Year
Facility:
Regional Medical Center
Test System:
Commercially prepared CLSI-Exempt microbiological media from XYZ Media Company
Quality Control:
CLIA ‘88 regulations
Training of Personnel:
Completion of training documented in______
Competency Assessment:
New employees 6 months and 12 months after initial training
Testing Personnel:
Personnel trained in media receipt and ongoing assessment
Summary of Isolates:
During the assessment period, microbiology cultures performed with exempt media type
Temperature Monitoring:
Corrective actions as per LAB-SOP-XXX
Manufacturer:
XYZ Media Company
Scientific Publications Used:
NCCLS (CLSI): Quality Control for Commercially Prepared Microbiological Culture Media
Note:
Year
Year:
2016
Region / City:
United States
Topic:
Proposal Checklist
Document Type:
Proposal Guidelines
Agency / Organization:
General Services Administration (GSA)
Author:
General Services Administration (GSA)
Target Audience:
Contractors submitting proposals
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Context:
This is a checklist to assist offerors in ensuring that proposals are complete when submitting to the General Services Administration (GSA).
Medicine:
Ciclosporin 1 mg/mL (0.1%) eye drops
Brand name:
Ikervis®
Sponsor:
Seqirus (Australia) Pty Ltd
Regulatory authority:
Therapeutic Goods Administration (TGA)
Registration date:
11 December 2020
Program:
Pharmaceutical Benefits Scheme (PBS)
Restriction type:
Authority Required (Streamlined)
Schedule category:
GENERAL – General Schedule (Code GE)
Indication:
Treatment of severe keratitis in adult patients with dry eye disease not improved despite tear substitutes
Population:
Patients aged 18 years or older with severe keratitis and dry eye disease
Comparators:
Best supportive care including preservative free artificial tears
Clinical criteria (initiation):
Corneal fluorescein staining grade 4 (modified Oxford scale or equivalent) and OSDI ≥ 23; failure of optimised preservative free tear substitutes
Clinical criteria (continuation):
Demonstrated adequate response at 6 months
Definition of adequate response:
Improvement in CFS ≥ 3 grades and ≥ 30% improvement in OSDI from baseline
Prescriber restrictions:
Ophthalmologist or optometrist
Economic basis:
Cost-utility analysis versus best supportive care
Proposed treatment phases:
Initiation; continuation; continuation after assessment of response
Year:
2024
Region / City:
United States
Topic:
Telecommunications
Document Type:
Public Notice
Organization:
Federal Communications Commission (FCC)
Author:
Wireline Competition Bureau
Target Audience:
Educational institutions, Charter schools, and applicants of the E-Rate program
Effective Period:
Ongoing
Approval Date:
June 3, 2024
Amendment Date:
N/A
Year:
2025–2026
Region:
United States Territories
Subject:
Program data collection for eligibility verification
Document type:
Attachment / Guidance Form
Issuing authority:
U.S. Department of Agriculture, Food and Nutrition Service
Related programs:
SNAP, TANF, Medicaid, Head Start, Foster, Homeless, Migrant, Runaway
Target audience:
School administrators and program operators
Data confidentiality:
Required under 7 CFR 292.12(b)-(d)
Data period:
July 1, 2025 – end of SOP 2026
Data sharing:
May include internal program use and inter-agency data transfers
Data collection schedule:
Includes initial and final pull dates and frequency of data updates
Year:
2021
Region / City:
United States
Subject:
Requests for waiver, review, and reconsideration of decisions related to the Universal Service Administrative Company actions
Document type:
Public Notice
Author:
Federal Communications Commission (FCC)
Target audience:
Telecommunications service providers, school districts, libraries, rural health care programs, and other entities involved in the Universal Service Fund
Period of validity:
March 31, 2021, and ongoing
Approval date:
March 31, 2021
Date of amendments:
None indicated
Contextual description:
A public notice issued by the FCC regarding the resolution of various waiver, review, and reconsideration requests filed by educational institutions, telecommunications providers, and rural health care programs.
Note:
Year
Region / City:
Alberta
Subject:
Family Law
Document Type:
Court Order
Authority / Organization:
Court of King’s Bench of Alberta
Author:
Justice of the Court of King’s Bench of Alberta
Target Audience:
Parties involved in family court proceedings
Year:
2023
Region / City:
United Kingdom
Theme:
Professional Accreditation
Document Type:
Application Form
Organization / Institution:
British Association for Counselling and Psychotherapy (BACP)
Author:
British Association for Counselling and Psychotherapy (BACP)
Target Audience:
Registered BACP members seeking accreditation
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Organization:
XYZ Community-Based Care, Inc.
Document type:
Cost Allocation Plan
Sector:
Child welfare
Jurisdiction:
Florida, United States
Regulatory framework:
2 CFR Part 200
Allocation method:
Direct Allocation Method
Accounting basis:
Current reporting month
Certifying authority:
Chief Executive Officer
Related systems:
Florida Safe Families Network (FSFN)
Related plans:
Public Assistance Cost Allocation Plan (PACAP)
Attachments:
Position Listing; Sub-contract Listing; Title IV-E Maintenance; Organization Chart; Chart of Accounts
Jurisdiction:
State of Oklahoma
Document type:
Legal release
Subject matter:
Employment law and severance
Governing laws:
Federal and Oklahoma employment and anti-discrimination statutes
Parties:
State of Oklahoma; XYZ Agency; employee
Related agreements:
Voluntary Separation Agreement
Effective date:
Date of signing in 2015
Exclusions:
Age Discrimination in Employment Act; workers’ compensation claims
Enforcement authorities:
Equal Employment Opportunity Commission; Department of Labor
Legal source category:
Employment and civil rights law document
Year:
20xx
Region / City:
Louisiana
Subject:
Agreed-Upon Procedures, Compliance and Control Review
Document Type:
Engagement Letter
Organization / Institution:
CPA Firm
Author:
CPA Firm
Target Audience:
Entity Head, Louisiana Legislative Auditor (LLA)
Period of Validity:
Fiscal period ended June 30, 20xx
Approval Date:
[Date]
Date of Modifications:
[Date]
Year:
2011
Region / city:
Nigeria
Subject:
Company Formation, Memorandum of Association, Articles of Association
Document Type:
Legal document, Corporate governance document
Organ / institution:
Federal Republic of Nigeria
Author:
Not specified
Target Audience:
Corporate stakeholders, legal professionals, business founders
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
USA
Topic:
Pharmaceutical submission
Document Type:
Submission of promotional materials
Organization:
FDA
Author:
John Doe
Target Audience:
FDA reviewers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Context:
A submission document for promotional materials related to a pharmaceutical product, including clean and annotated versions of the materials, as well as FDA-approved PI and Medication Guide.
Version:
1.00
Updated:
01/01/2000
Author:
John Smith
Year:
2000
Region / City:
N/A
Topic:
Solution Design Documentation
Document Type:
Template
Organization / Institution:
N/A
Target Audience:
Project teams, engineers, developers
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
01/01/2000